What is Haemonetics's repayments of long-term lines of credit?

Haemonetics (HAE) reported repayments of long-term lines of credit of $0 in Q1 2026.

What is the long-term trend for Haemonetics's repayments of long-term lines of credit?

Over 2 years (2023 to 2026), Haemonetics's repayments of long-term lines of credit has grown at a -100.0% compound annual growth rate (CAGR), from $50M to $0.

Haemonetics HAE Repayments of Long-Term Lines of Credit

Repayments of Long-Term Lines of Credit at other companies

StepStone Group Inc.STEP

$18.75M-57.1%

Target HospitalityTH

$18.6M-45.5%

EAT

Brinker InternationalEAT

$195M-30.4%

Comfort Systems USAFIX

$100M+300%

CoherentCOHR

$373.52M+994%

BlockXYZ

$1.07B-2.4%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermLinesOfCredit.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's repayments of long-term lines of credit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's repayments of long-term lines of credit?: Haemonetics (HAE) reported repayments of long-term lines of credit of $0 in Q1 2026.
What is the long-term trend for Haemonetics's repayments of long-term lines of credit?: Over 2 years (2023 to 2026), Haemonetics's repayments of long-term lines of credit has grown at a -100.0% compound annual growth rate (CAGR), from $50M to $0.